• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为癌症常规临床应用选择、实施和评估患者报告的结局指标:安大略癌症护理的方法。

Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: the Cancer Care Ontario approach.

作者信息

Montgomery Nicole, Howell Doris, Ismail Zahra, Bartlett Susan J, Brundage Michael, Bryant-Lukosius Denise, Krzyzanowska Monika, Moody Lesley, Snyder Claire, Barbera Lisa

机构信息

Cancer Care Ontario, Toronto, Canada.

University Health Network, Toronto, Canada.

出版信息

J Patient Rep Outcomes. 2020 Nov 26;4(1):101. doi: 10.1186/s41687-020-00270-1.

DOI:10.1186/s41687-020-00270-1
PMID:33242136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7691418/
Abstract

BACKGROUND

The use of Patient-Reported Outcome Measures (PROMs) in routine clinical care can help ensure symptoms are identified, acknowledged and addressed. In 2007, the provincial cancer agency, Cancer Care Ontario, began to implement routine symptom screening with the Edmonton Symptom Assessment System (ESAS) for ambulatory cancer patients. Having had a decade of experience with ESAS, the program developed a strategic interest in implementing new and/or additional measures. This article describes the development of a streamlined PROM selection and implementation evaluation process with core considerations.

METHODS

Development of the PROM selection and implementation evaluation process involved analysis of quantitative and qualitative data as well as consensus building through a multi-stakeholder workshop. Core PROM selection considerations were developed through a literature scan, review and refinement by a panel of methodological experts and patient advisors, and testing via a test case. Core PROM implementation evaluation considerations were developed through analysis of PROM evaluation frameworks, and review and refinement by a committee of provincial implementation leads.

RESULTS

Core PROM selection considerations were identified under three overarching themes: symptom coverage, usability and psychometric properties. The symptom coverage category assesses each PROM to determine how well the PROM items address the most prevalent and burdensome symptoms in the target patient population. The usability category aims to assess each measure on characteristics key to successful implementation in the clinical setting. The psychometric properties category assesses each PROM to ensure the data collected is credible, meaningful and interpretable. A scoring system was developed to rate PROM performance by assigning a grade of "weak", "average" or "good" for each category. The process results in a summary matrix which illustrates the overall assessment of each PROM. Implementation evaluation considerations were identified under three overarching concepts: acceptability, outcomes, and sustainability. A consensus building exercise resulted in the further identification of patient, provider, and clinic specific indicators for each consideration.

CONCLUSION

To address the need for a systematic, evidence-based approach to selection, implementation and evaluation of PROMs in the clinical setting, Cancer Care Ontario defined a process with embedded core considerations to facilitate decision-making and encourage standardization.

摘要

背景

在常规临床护理中使用患者报告结局测量指标(PROMs)有助于确保症状得到识别、确认和处理。2007年,省级癌症机构安大略癌症护理中心开始对门诊癌症患者采用埃德蒙顿症状评估系统(ESAS)进行常规症状筛查。在使用ESAS十年后,该项目对实施新的和/或额外的测量指标产生了战略兴趣。本文介绍了一个简化的PROM选择和实施评估流程以及核心考量因素。

方法

PROM选择和实施评估流程的制定涉及定量和定性数据分析,以及通过多利益相关方研讨会达成共识。核心PROM选择考量因素通过文献检索、由方法学专家和患者顾问组成的小组进行审查和完善,并通过一个测试案例进行测试来确定。核心PROM实施评估考量因素通过对PROM评估框架的分析以及由省级实施负责人组成的委员会进行审查和完善来确定。

结果

在三个总体主题下确定了核心PROM选择考量因素:症状覆盖范围、可用性和心理测量特性。症状覆盖范围类别评估每个PROM,以确定PROM项目在多大程度上解决了目标患者群体中最普遍和最具负担的症状。可用性类别旨在根据在临床环境中成功实施的关键特征评估每个测量指标。心理测量特性类别评估每个PROM,以确保收集到的数据可信、有意义且可解释。开发了一个评分系统,通过为每个类别分配“弱”“中等”或“好”的等级来对PROM性能进行评分。该流程产生一个汇总矩阵,展示了对每个PROM的总体评估。在三个总体概念下确定了实施评估考量因素:可接受性、结果和可持续性。通过一次共识达成活动进一步确定了针对每个考量因素的患者、提供者和诊所特定指标。

结论

为满足临床环境中对PROMs进行系统、循证选择、实施和评估的需求,安大略癌症护理中心定义了一个包含核心考量因素的流程,以促进决策制定并鼓励标准化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c5/7691418/d7079a4fe40d/41687_2020_270_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c5/7691418/d7079a4fe40d/41687_2020_270_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c5/7691418/d7079a4fe40d/41687_2020_270_Fig1_HTML.jpg

相似文献

1
Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: the Cancer Care Ontario approach.为癌症常规临床应用选择、实施和评估患者报告的结局指标:安大略癌症护理的方法。
J Patient Rep Outcomes. 2020 Nov 26;4(1):101. doi: 10.1186/s41687-020-00270-1.
2
3
Development of a framework with tools to support the selection and implementation of patient-reported outcome measures.开发一个带有工具的框架,以支持患者报告结局测量指标的选择与实施。
J Patient Rep Outcomes. 2019 Dec 30;3(1):75. doi: 10.1186/s41687-019-0171-9.
4
Selection of patient-reported outcome measures (PROMs) for use in health systems.用于卫生系统的患者报告结局指标(PROMs)的选择
J Patient Rep Outcomes. 2021 Oct 12;5(Suppl 2):99. doi: 10.1186/s41687-021-00374-2.
5
Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review.实施患者报告结局测量在临床乳腺癌护理中的应用:系统评价。
Value Health. 2019 Oct;22(10):1197-1226. doi: 10.1016/j.jval.2019.04.1927. Epub 2019 Aug 29.
6
Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings.采用实施科学方法在常规护理环境中实施和评估患者报告的结果测量(PROM)措施。
Qual Life Res. 2021 Nov;30(11):3015-3033. doi: 10.1007/s11136-020-02564-9. Epub 2020 Jul 10.
7
A systematic review of patient-reported outcome measurement (PROM) and provider assessment in mental health: goals, implementation, setting, measurement characteristics and barriers.心理健康患者报告结局测量(PROM)和提供者评估的系统评价:目标、实施、环境、测量特征和障碍。
Int J Qual Health Care. 2021 Mar 5;34(Suppl 1):ii13–ii27. doi: 10.1093/intqhc/mzz133.
8
Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist.评估膀胱癌患者报告结局测量指标(PROMs):使用共识基础的健康测量仪器选择标准(COSMIN)清单进行的系统评价。
BJU Int. 2018 Nov;122(5):760-773. doi: 10.1111/bju.14368. Epub 2018 Jun 8.
9
"You need a team": perspectives on interdisciplinary symptom management using patient-reported outcome measures in hemodialysis care-a qualitative study.“需要一个团队”:使用患者报告结局测量对血液透析护理进行跨学科症状管理的观点——一项定性研究。
J Patient Rep Outcomes. 2023 Jan 20;7(1):3. doi: 10.1186/s41687-022-00538-8.
10
Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada.在加拿大安大略省进行大规模基于人群的实施后,癌症护理专业人员对系统标准化症状评估及埃德蒙顿症状评估系统的态度
J Pain Symptom Manage. 2016 Apr;51(4):662-672.e8. doi: 10.1016/j.jpainsymman.2015.11.023. Epub 2015 Dec 30.

引用本文的文献

1
INDIGO randomised controlled digital clinical trial: INvestigating DIgital outcomes and quality of life in cancer survivors - a study protocol.INDIGO随机对照数字临床试验:调查癌症幸存者的数字结局和生活质量——一项研究方案。
BMJ Open. 2025 Sep 8;15(9):e104336. doi: 10.1136/bmjopen-2025-104336.
2
Optimizing Patient Engagement with Patient-Reported Outcome Measures Across the Cancer Continuum: A Qualitative Study.优化癌症全程中患者报告结局指标的患者参与度:一项定性研究。
Palliat Med Rep. 2025 Jun 5;6(1):333-341. doi: 10.1089/pmr.2025.0029. eCollection 2025.
3
Exploring the Impact of Physical Therapy on Patient Outcomes Across the Cancer Care Continuum: A Narrative Review.

本文引用的文献

1
Use of patient-reported outcomes in regional cancer centres over time: a retrospective study.区域癌症中心随时间推移对患者报告结局的使用:一项回顾性研究。
CMAJ Open. 2019 Feb 18;7(1):E101-E108. doi: 10.9778/cmajo.20180074. Print 2019 Jan-Mar.
2
A pilot evaluation of the expanded prostate cancer index composite for clinical practice (EPIC-CP) tool in Ontario.安大略省扩大前列腺癌指数复合临床实践评估工具(EPIC-CP)的初步评估。
Qual Life Res. 2019 Mar;28(3):771-782. doi: 10.1007/s11136-018-2034-x. Epub 2018 Oct 31.
3
Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR).
探索物理治疗对癌症护理全程患者结局的影响:一项叙述性综述
Cureus. 2025 Jul 1;17(7):e87144. doi: 10.7759/cureus.87144. eCollection 2025 Jul.
4
Associations Between Symptom Complexity and Acute Care Utilization Among Adult Advanced Cancer Patients Followed by a Palliative Care Service.接受姑息治疗服务的成年晚期癌症患者症状复杂性与急性护理利用之间的关联。
Curr Oncol. 2025 Jul 4;32(7):388. doi: 10.3390/curroncol32070388.
5
Patienteported utcomes (PROs) as cancer care: report from a 2023 Australian consensus meeting (PROActive).患者报告结局(PROs)在癌症护理中的应用:2023年澳大利亚共识会议(PROActive)报告
EClinicalMedicine. 2025 Jun 23;85:103295. doi: 10.1016/j.eclinm.2025.103295. eCollection 2025 Jul.
6
A rapid state-of the-art review of client-reported outcomes measures used to assess dogs' clinical signs and quality of life during chemotherapy.对用于评估犬化疗期间临床症状和生活质量的患者报告结局指标的最新快速综述。
BMC Vet Res. 2025 Feb 18;21(1):74. doi: 10.1186/s12917-025-04522-4.
7
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how.测量近距离放射治疗中患者报告的结局:我们为何要这样做,更重要的是如何去做。
Clin Transl Radiat Oncol. 2024 Oct 2;49:100870. doi: 10.1016/j.ctro.2024.100870. eCollection 2024 Nov.
8
Healthcare consumer acceptability of routine use of the EQ-5D-5L in clinical care: a cross-sectional survey.医疗保健消费者对在临床护理中常规使用EQ-5D-5L的可接受性:一项横断面调查。
Qual Life Res. 2024 May;33(5):1307-1321. doi: 10.1007/s11136-024-03598-z. Epub 2024 Feb 7.
9
The use of patient reported outcome measures in oncology clinical practice across Australia and New Zealand.在澳大利亚和新西兰的肿瘤临床实践中使用患者报告结局测量。
J Patient Rep Outcomes. 2024 Jan 2;8(1):1. doi: 10.1186/s41687-023-00664-x.
10
Importance of Incorporating the Perspectives of People with Cancer into Oncology Education: A Scoping Review.将癌症患者的观点纳入肿瘤学教育的重要性:一项范围综述
J Med Educ Curric Dev. 2023 Dec 17;10:23821205231219394. doi: 10.1177/23821205231219394. eCollection 2023 Jan-Dec.
提交给泛加拿大肿瘤药物评审(pCODR)的经济评估中的方法学问题。
Pharmacoecon Open. 2017 Dec;1(4):255-263. doi: 10.1007/s41669-017-0018-3.
4
Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research.省级开展患者报告结局倡议,以指导患者护理、质量改进和研究。
Healthc Manage Forum. 2018 Jan;31(1):13-17. doi: 10.1177/0840470417715478.
5
The struggle of translating science into action: Foundational concepts of implementation science.将科学转化为行动的斗争:实施科学的基础概念。
J Eval Clin Pract. 2018 Feb;24(1):117-126. doi: 10.1111/jep.12741. Epub 2017 Mar 31.
6
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.常规癌症治疗期间通过患者报告结局进行症状监测:一项随机对照试验。
J Clin Oncol. 2016 Feb 20;34(6):557-65. doi: 10.1200/JCO.2015.63.0830. Epub 2015 Dec 7.
7
The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research.专业人员运用患者报告结局测量信息以提高医疗质量的经验:一项定性研究的系统评价
BMJ Qual Saf. 2014 Jun;23(6):508-18. doi: 10.1136/bmjqs-2013-002524. Epub 2014 Feb 6.
8
The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors.在白血病、膀胱癌和结直肠癌幸存者的随访护理中,症状监测的重要性。
Support Care Cancer. 2014 Jan;22(1):163-72. doi: 10.1007/s00520-013-1961-x. Epub 2013 Sep 10.
9
A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting.在肿瘤学环境中,系统评价常规收集患者报告的结果测量对患者、提供者和卫生组织的影响。
BMC Health Serv Res. 2013 Jun 11;13:211. doi: 10.1186/1472-6963-13-211.
10
Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis.患者报告的症状能否预测癌症患者的急诊科就诊?一项基于人群的分析。
Ann Emerg Med. 2013 Apr;61(4):427-437.e5. doi: 10.1016/j.annemergmed.2012.10.010. Epub 2013 Jan 4.